Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, formerly known by OMP-131R10, constitutes a unique monoclonal protein engineered to inhibit granulocyte-macrophage colony-stimulating FMS-like tyrosine kinase. https://www.targetmol.com/compound/rosmantuzumab